Business Context and Reporting Period
Company: Prestige Consumer Healthcare Inc. (filing as Prestige Brands Holdings, Inc. and Prestige Brands International, LLC)
Reporting Period: Quarterly period ended December 31, 2005 (Nine months ended December 31, 2005)
Business Overview: The Company markets, sells, and distributes over-the-counter (OTC) drugs, personal care, and household cleaning brands to mass merchandisers, drug stores, and supermarkets. The Company completed an Initial Public Offering (IPO) in February 2005. During the period, the Company acquired the "Chore Boy" brand (October 2005) and Dental Concepts, LLC ("The Doctor's" brand) (November 2005).
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Dec 31, 2005 | Nine Months Ended Dec 31, 2005 |
|---|---|---|
| Net Sales | $79,829 | $216,577 |
| Gross Profit | $41,130 | $113,430 |
| Gross Margin % | 51.5% | 52.4% |
| Operating Income | $24,752 | $63,836 |
| Net Income | $9,345 | $22,648 |
| Diluted EPS | $0.19 | $0.45 |
| Cash and Equivalents | $9,646 | $9,646 (Ending Balance) |
| Total Debt (Long-term + Current) | $517,563 | $517,563 (Ending Balance) |
| Net Cash Provided by Operating Activities | N/A | $35,836 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.3% ($6.9 million) for the quarter and 2.3% ($4.9 million) for the nine-month period compared to the prior year. Growth was driven by the Household Cleaning segment (+25.9% quarterly) and acquisitions (Chore Boy, Dental Concepts), partially offset by declines in the Personal Care segment (-7.9% quarterly).
- Profitability: Operating income decreased 6.0% for the quarter ($24.8M vs $26.3M) due to increased advertising and promotion spending ($2.2M increase) and higher petroleum costs impacting gross margins. However, for the nine-month period, operating income increased 5.0% ($63.8M vs $60.8M).
- Net Income: Net income increased 2.4% for the quarter and 90.0% for the nine-month period. The significant nine-month increase is largely due to a $7.6 million loss on extinguishment of debt recorded in the prior year period, which did not recur in 2005.
- Debt Reduction: Interest expense decreased 20.6% for the quarter and 21.2% for the nine-month period, reflecting the repayment of significant indebtedness using IPO proceeds in February 2005.
Guidance, Outlook, Risks, and Contingencies
- Management Commentary: Management attributes sales declines in certain OTC brands (Chloraseptic, Clear Eyes, Compound W) to supply issues, backorder fulfillment timing, and category softness. Gross margin compression is attributed to higher petroleum costs and product mix changes.
- Legal Proceedings:
- Securities Class Action: The Company is a defendant in a consolidated putative securities class action lawsuit alleging false/misleading statements regarding accounting issues and declining product demand. Plaintiffs seek unspecified damages. Management intends to file a motion to dismiss.
- Trade Dress Litigation: An appeal is pending regarding a trade dress infringement lawsuit (Theodosakis v. Walgreens) involving the ARTHx trademarks, which were sold in 2003. The Company previously won summary judgment.
- Legal Fees: The Company incurred significant legal and accounting fees related to a special investigation by the Board of Directors and the restatement of historical financial results.
- Internal Controls: The Company implemented controls to remediate material weaknesses in internal control over financial reporting identified in the prior quarter, specifically regarding revenue recognition (SAB 104) and promotion classification (EITF 01-09). Management concluded controls were effective as of December 31, 2005.
- Liquidity: The Company has $35.0 million of borrowing capacity available under its Revolving Credit Facility. Management believes cash flows and available borrowings are sufficient for the next 12 months.
Investor Verification Checklist
- Restatement Impact: Verify the full extent of the historical financial restatement and the specific accounting adjustments made regarding revenue recognition and promotional allowances.
- Legal Exposure: Monitor the status of the consolidated securities class action lawsuit and the potential for material damages or settlement costs.
- Acquisition Integration: Assess the performance of the newly acquired "Chore Boy" and "The Doctor's" brands against management's expectations for sales growth and margin contribution.
- Margin Pressure: Track the impact of rising petroleum and raw material costs on gross margins, particularly in the Household Cleaning and Personal Care segments.
- Debt Covenants: Confirm continued compliance with financial covenants (leverage, interest coverage) under the Senior Credit Facility, especially given the high debt load relative to equity.